Vaccine Development Centre Offers Advantages for VIDO and for Canada
The Director of Research with the Vaccine and Infectious Disease Organization says an in-house Vaccine Development Centre offers a number of advantages for both VIDO and Canada
by Bruce Cochrane – Farmscape.ca
The Vaccine and Infectious Disease Organization’s new pilot scale vaccine manufacturing facility will provide vaccines for veterinary use and human use, including live attenuated and killed vaccines, subunit-based and viral vector-based vaccines and some of the newer technologies such as RNA and DNA based vaccines.
Dr. Andrew van Kessel, the Director of Research at VIDO, says a vaccine manufacturing facility has been in VIDO’s sights for many years and having in-house manufacturing offers advantages for both VIDO and the country.
“We very much look forward to serving the livestock industry going forward and the Vaccine Development Centre is very much a part of that vision”
Our September 2025 Issue
In our September 2025 issue, Beef Advocacy Canada relaunches new platform, U.S. shuts the door on small exporters, The future of meat, John Deere tariff warning, Shrugging off high beef prices, Geopolitics and Bird Flu, The reshaped meat processing industry, Rethinking Ag trade, and much more!
